Drug · DIN 02500299
KYNMOBI
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since September 29, 2023; first marketed November 17, 2020.
- Drug Identification Number (DIN)
- 02500299
- Company (DIN owner)
- Sunovion Pharmaceuticals Canada IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Film (Soluble)
- Route
- Sublingual
- Therapeutic class (ATC)
- Apomorphine N04BC07
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| APOMORPHINE HYDROCHLORIDE | 25 MG | FILM |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 12, 2020: NOC 23773New Drug Submission (NDS)
Other DINs named KYNMOBI
- DIN 02500264 · Cancelled Post Market
- DIN 02500272 · Cancelled Post Market
- DIN 02500280 · Cancelled Post Market
- DIN 02500302 · Cancelled Post Market